Information  X 
Enter a valid email address

Hikma Pharm PLC Ord Shs 10P (HIK)

Related News

17-Feb-2020 10:10 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to neutral (from buy). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
21-Jan-2020 10:30 AM

Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC

Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 2240p (from 2310p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Jan-2020 10:40 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to underweight (from neutral) and raised its price target to 1850p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by ww
03-Dec-2019 10:10 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1800p (from 1700p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk..
07-Nov-2019 07:16 AM

Hikma Pharmaceuticals says revenue from generics business to be at top end of range

Hikma Pharmaceuticals said it expected revenues in its generics business to be closer to the top end of its guidance range following strong demand and operational improvements. For the full year, the pharma company said it now expected generics revenue
20-Aug-2019 08:40 AM

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1900p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.u
09-Aug-2019 09:30 AM

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2050p (from 1870p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
17-May-2019 07:44 AM

Hikma Pharmaceuticals on track to meet expectations amid 'good' start to year

Hikma Pharmaceuticals said it was on track to meet full-year expectations following a 'good start' to the year, driven by recent product launches and good demand across all three businesses for its products. Its injectables business was perfo
21-Mar-2019 10:00 AM

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1800p (from 1950p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk..
19-Mar-2019 10:10 AM

Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC

Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1960p (from 2000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
19-Mar-2019 10:00 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from neutral). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Mar-2019 12:10 PM

Broker Forecast - HSBC issues a broker note on Hikma Pharmaceuticals PLC

HSBC today reaffirms its reduce investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1350p (from 1225p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-Mar-2019 09:10 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1700p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Mar-2019 08:03 AM

Hikma Pharmaceuticals swings to profit led by ongoing growth in injectables business

Hikma Pharmaceuticals swung to a profit on Wednesday after it boosted injectables revenue, though it warned of lower sales in its generics business due to price cuts. For the 12 months to 31 December, the company reported a profit of $408m compared with
12-Mar-2019 09:00 AM

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its price target to 1870p (from 2000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
27-Nov-2018 10:00 AM

Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC

Jefferies International today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from hold) and raised its price target to 2000p (from 1643p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesm
20-Nov-2018 02:30 PM

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1900p (from 1050p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk..
12-Nov-2018 08:10 AM

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to hold (from add) and raised its price target to 2000p (from 1950p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.
09-Nov-2018 10:10 AM

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today reaffirms its equal weight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 1950p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.u
08-Nov-2018 10:26 AM

Hikma Pharmaceuticals lifts revenue guidance following 'strong' Q3

Hikma Pharmaceuticals raised its full-year revenue guidance for both its injectables generic businesses after reporting 'strong' performance in the third quarter of the year. The company said it expected Injectables revenue to be in the range
06-Nov-2018 10:00 AM

Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC

Barclays Capital today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to equal weight (from underweight) and raised its price target to 1800p (from 1400p). Story provided by StockMarketWire.com Broker Forecasts data provided by ww
03-Oct-2018 08:50 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2250p (from 2100p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
20-Aug-2018 09:00 AM

Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC

Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and raised its price target to 2100p (from 1675p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
16-Aug-2018 08:30 AM

Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC

Peel Hunt today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to add (from hold) and raised its price target to 1950p (from 1160p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk.
15-Aug-2018 08:54 AM

Hikma Pharmaceuticals ups guidance as results top expectations

Hikma Pharmaceuticals raised guidance Wednesday for its injectables and generics businesses after reporting a jump in first-half profits. Injectables revenue is expected within a range of $775m to $825m and core operating margin for the full year to be
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t